Sucampo, Takeda obtain expanded approval for Amitiza

04/23/2013 | CNBC

The FDA has granted Sucampo Pharmaceuticals and Takeda Pharmaceuticals expanded approval for their Amitiza drug to treat constipation from opioids used for chronic pain. Forty percent or more of patients who use opioids for chronic pain not associated with cancer experience constipation, the companies said.

View Full Article in:

CNBC

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA